Jared Sokol, MD
Ophthalmology · Aurora
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 2 carriers
- Offices
- 2
- Since medical school
- 7 years
- University of Chicago, Pritzker School of Medicine, 2019
Offices
2 locations · University Physicians Incorporated · Denver Health and Hospital Authority
Hospitals listed: University of Colorado Hospital Authority. That is not proof they admit you there this week.
Plans that list them
17 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sokol’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A185417 · Current
Licensed to practise in California · since 2023 · expires 2027-04-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Colorado DR.75645Physician · since 2025 · expires 2027-04-30Specialty on the licence: OpthamologyMatched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the stateWhat they told the state about themselves
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
- Ophthalmology
Education
- Uni of Chicago Div Bio Sci Pritzker School of Med2019
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Palo Alto Medical Foundation · Palo Alto, CA
- Stanford Health Care · Palo Alto, CA
- VA Medical Center Palo Alto · Palo Alto, CA
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
California · Illinois · Massachusetts
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University of Colorado Hospital AuthorityAurora, COAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of Colorado Health, which runs 12 hospitals in 2 statesHome of University of Colorado Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.33 (1.15 to 1.52), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.19 (2.14 to 4.24) · 2,906 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.54 (1.12 to 1.96) · 10,774 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.492, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.566, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.279, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 9 (7.8 to 10.5) · 1,332 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for University of Colorado Hospital Authority
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 1 better, 10 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.33 (1.15 to 1.52) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.19 (2.14 to 4.24) · 2,906 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.54 (1.12 to 1.96) · 10,774 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.492 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.566 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.279 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (7.8 to 10.5) · 1,332 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.58 to 1.98) · 3,487 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.29 (144.06 to 206.51) · 400 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 317 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.8 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 366 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 5,078 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.09 to 0.44) · 11,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 13,154 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.43 (2.12 to 4.74) · 5,027 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (1.25 to 3.33) · 4,375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.4 (7.01 to 13.78) · 2,655 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.8 (2.76 to 6.83) · 2,855 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.34 to 2.79) · 1,608 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 88 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.59 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.29 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.896 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.1 · 530 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.9 · 113 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 11.1 · 461 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 655 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.7 to 6.9) · 1,332 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 277 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12 (9.5 to 15.1) · 2,456 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,478 cases | No different | Jan 2024 – Dec 2024 |
What patients said (5,233 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$9,462
Medicare paid this office $9,462 for 92 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 37 | $2,017 | $55 |
| Return visit (30+ min) | 20 | $1,662 | $83 |
| Imaging of retina | 21 | $472 | $22 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
92 Original Medicare patients in 2024. Average age 75 · Women 51% · Also on Medicaid 34% · Health risk score 1.40. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 62% · Diabetes 28% · Coronary heart disease 27% · Chronic kidney disease 25% · Cancer 21% · Depression 17% · COPD 15% · Heart failure 14% · Atrial fibrillation 14%.
The office billed $150,744, Medicare allowed $12,683 and paid $9,462; for 122 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 92 | 122 | 75 | 1.40 | $150,744 | $9,462 |
| 2023 | 18 | 25 | 77 | 1.24 | $47,094 | $2,232 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$65,686
Pharmacies billed $65,686 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
120 generic and 111 brand-name prescriptions · $65,686 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 15 | $12,201 | $813 |
| Prednisolone Acetate | 34 | $1,247 | $37 |
| Cyclosporine | 11 | $885 | $80 |
| Dorzolamide-Timolol | 17 | $494 | $29 |
| Ketorolac Tromethamine | 19 | $300 | $16 |
See all 7 drugs
| Restasis | 15 | $12,201 | $813 |
| Prednisolone Acetate | 34 | $1,247 | $37 |
| Cyclosporine | 11 | $885 | $80 |
| Dorzolamide-Timolol | 17 | $494 | $29 |
| Ketorolac Tromethamine | 19 | $300 | $16 |
| Erythromycin | 17 | $205 | $12 |
| Latanoprost | 26 | $92 | $4 |
Year by year
| 2024 | 231 | 115 | None | 48% | $65,686 |
| 2023 | 162 | 68 | 0% (0) | 39% | $51,546 |
| 2022 | 99 | 47 | 0% (0) | 16% | $2,813 |
| 2021 | 143 | 71 | None | 35% | $5,761 |
| 2020 | 43 | 29 | None | None | $1,911 |
| 2019 | 36 | 19 | 0% (0) | None | $605 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Restasis | 13 | $12,372 | $952 |
| Prednisolone Acetate | 25 | $1,104 | $44 |
| Ketorolac Tromethamine | 21 | $461 | $22 |
| Moxifloxacin | 11 | $415 | $38 |
| Dorzolamide-Timolol | 20 | $374 | $19 |
| Erythromycin | 11 | $229 | $21 |
| Latanoprost | 18 | $188 | $10 |
2022: 3 drugs
| Prednisolone Acetate | 15 | $649 | $43 |
| Ketorolac Tromethamine | 15 | $547 | $36 |
| Erythromycin | 26 | $546 | $21 |
2021: 3 drugs
| Prednisolone Acetate | 31 | $2,007 | $65 |
| Ketorolac Tromethamine | 31 | $1,862 | $60 |
| Erythromycin | 31 | $654 | $21 |
Money from drug and device companies
$191 in 2025
| 2025 | 2 | 2 | None | $191 |
| 2024 | 3 | 3 | None | $372 |
| 2023 | 3 | 3 | None | $305 |
| 2022 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma Global Development | Izervay | $160 | 1 payment
|
| Apellis Pharmaceuticals | Syfovre | $31 | 1 payment
|
See all 2 published payments
| Astellas Pharma Global Development | Meals · 2025-06-17 | Izervay | $160 |
| Apellis Pharmaceuticals | Meals · 2025-04-29 | Syfovre | $31 |
See earlier years (2024, 2023, 2022)
2024: $372
| Astellas Pharma US | Izervay | $150 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea Hd | $127 | 1 payment
|
| Regeneron Pharmaceuticals | Eylea | $94 | 1 payment
|
2023: $305
| Astellas Pharma US | None | $149 | 1 payment
|
| Regeneron Pharmaceuticals | None | $124 | 1 payment
|
| Dutch Ophthalmic USA | Eva, Combined Machine | $32 | 1 payment
|
2022: $125
| Alcon Vision | Constellation | $125 | 1 payment
|
Professional record
- NPI
- 1356802904
- Licence
- CA A185417California A185417: Current · expires 2027-04-30Colorado DR.75645: Active
- Trained
- University of Chicago, Pritzker School of Medicine, 2019 · 7 years ago
- Group
- University Physicians Incorporated · Denver Health and Hospital Authority
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0107X (207WX0107X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- Po Box 110429, Aurora, CO, 80042
- NPI first listed
- 2019-03-27
- NPI last updated
- 2025-09-30
- NPI record certified
- 2025-09-30
This is when the NPI record was last certified, not a medical board exam.